Phosphate levels and cardiovascular disease in the general population.
about
The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesisFibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort.Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study.Increased systemic inflammation is associated with cardiac and vascular dysfunction over the first 12 weeks of antiretroviral therapy among undernourished, HIV-infected adults in Southern Africa.Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.High Serum Phosphorus Level Is Associated with Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis PatientsLiver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters.Nutrition in Cardioskeletal Health.Parathyroid ultrasonography and bone metabolic profile of patients on dialysis with hyperparathyroidism.FGF-23 is associated with increased disease severity and early mortality in cardiogenic shockPhosphate: an old bone molecule but new cardiovascular risk factor.Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: rationale and design of the EARNEST study.Defining, Treating, and Understanding Chronic Kidney Disease--A Complex Disorder.Mineral and bone disorders, morbidity and mortality in end-stage renal failure patients on chronic dialysis.Elevated serum phosphate levels are associated with decreased amputation-free survival after interventions for critical limb ischemia.Inorganic Phosphate Activates the AKT/mTORC1 Pathway and Shortens the Life Span of an α‑Klotho-Deficient Model.Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: cross-sectional findings from the Avon Longitudinal Study of Parents and Children.Associations of childhood 25-hydroxyvitamin D2 and D3 and cardiovascular risk factors in adolescence: prospective findings from the Avon Longitudinal Study of Parents and Children.Phosphorus metabolism in chronic kidney disease.Utilizing Dietary Micronutrient Ratios in Nutritional Research May be More Informative than Focusing on Single Nutrients.Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy.Survival-Related Autophagic Activity Versus Procalcific Death in Cultured Aortic Valve Interstitial Cells Treated With Critical Normophosphatemic-Like Phosphate Concentrations.Sensing of phosphates by using luminescent Eu(III) and Tb(III) complexes: application to the microalgal cell Chlorella vulgaris.Interaction of Serum Phosphate with Age as Predictors of Cardiovascular Risk Scores in Stable Renal Transplant Recipients.Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial.Phosphate excretion is decreased in older cardiac patients with normal kidney function: an emerging dietary risk factor?Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification.Autophagy Protects From Uremic Vascular Media Calcification
P2860
Q34027561-CF5DBC59-DCDB-4862-9E30-F6B571F45F44Q34187537-E694B60A-F228-44B2-B396-A4A8A6B4820BQ34244300-D64FAD3B-831F-4B8A-AB89-AF4A0EE9D72EQ35530311-D28F64C3-231A-41C4-A580-5B036374AAE3Q35668434-26AB66F4-3BB6-42B4-A39A-2CBA99DE55E5Q35837789-0B56DC64-BDB9-42D1-9AE3-6A09023854F2Q36142874-0EC9102D-3C9D-4092-82F0-12854103E8B6Q36191156-9E6154AA-B5A0-463A-A0DD-8090A1088F22Q36890341-7C2534B2-CD9B-47BB-B29F-4AE608CC3C07Q37231801-E17DFCB9-90C1-46BC-AC9B-15D97C2CEC19Q37291894-D96594A7-B3DB-48DE-B3F1-B56D9793334BQ37492019-7CED30F1-6444-4EC4-8B7A-D60022276948Q37522761-138EC5BE-31EC-477A-8FBD-82BCE0374E29Q38445037-114ED172-94DE-434F-929D-EBBF1AA9DF8BQ38765338-C0242A76-24BD-464D-9EE4-05337709DAF6Q38817814-026EB5B7-3F2F-4B2E-BACA-4622DC49ED9AQ40974207-202EA9AA-6C8C-4A83-9732-715069A51344Q41780200-C88B88B8-45B9-4DB1-8702-6EF6C6AAA2C6Q41971262-93BFA345-CC90-4152-8B62-61E45B9A0D82Q42123269-A733FE59-824F-4167-B00C-463B6D5CED31Q48207375-EAE5109A-C860-4E7B-B7E8-05130EDDC8AEQ50133293-1AD5F5E3-AE75-41A8-B725-8A4B88FEC100Q50188358-7435E703-4FC0-45AE-9828-41CB6D6CFA11Q50458364-B0FE90E1-2E62-4FDF-8975-46467ED50443Q50609788-5D40DEF7-BA3C-4DBF-A3F6-B029C2770623Q51246104-12726D99-37A9-4507-BD31-A95222254210Q55027071-C4490051-F1AD-4CC6-926B-4C7AF94B6D54Q55098165-6F23F8D4-846D-4DD0-AC04-5A19DED1C990Q58781668-E6C63FD0-A90B-4200-A48B-4A675AA3F93E
P2860
Phosphate levels and cardiovascular disease in the general population.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phosphate levels and cardiovascular disease in the general population.
@en
Phosphate levels and cardiovascular disease in the general population.
@nl
type
label
Phosphate levels and cardiovascular disease in the general population.
@en
Phosphate levels and cardiovascular disease in the general population.
@nl
prefLabel
Phosphate levels and cardiovascular disease in the general population.
@en
Phosphate levels and cardiovascular disease in the general population.
@nl
P356
P1476
Phosphate levels and cardiovascular disease in the general population.
@en
P2093
Robert N Foley
P304
P356
10.2215/CJN.01660309
P577
2009-05-07T00:00:00Z